Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

66.28 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2026 Add to My Watchlist

Price and Volume

Volume	220
Open	66.28
Bid (Size)	66.28 (1,000)
Ask (Size)	66.85 (200)
Prev. Close	66.28
Today's Range	66.28 - 66.28
52wk Range	51.06 - 82.22
Shares Outstanding	142,334,900
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Halozyme Therapeutics Inc (NASDAQ:HALO): A Deep Value Play Combining Strong Profitability with an Attractive 14.35 P/E ↗

Today 5:40 EDT

Via Chartmill

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 18, 2026

Halozyme Therapeutics’ first quarter results for 2026 were met with a positive market response, underpinned by substantial royalty revenue growth and the exp...

Via StockStory

Performance

YTD	-5.7%	-5.7%
1 Month	+2.6%	+2.6%
3 Month	-4.5%	-4.5%
6 Month	-0.4%	-0.4%
1 Year	+19.1%	+19.1%

More News

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

May 13, 2026

Via StockStory

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

May 12, 2026

Via StockStory

Halozyme Therapeutics (NASDAQ:HALO) Surges After Q1 Beat, Launches $1 Billion Buyback ↗

May 11, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Presents a Compelling Value Investment Case ↗

March 06, 2026

Via Chartmill

Halozyme Therapeutics Inc (NASDAQ:HALO) Reports Mixed Q4 2025 Results with Revenue Beat and Unexpected Loss ↗

February 17, 2026

Via Chartmill

HALOZYME THERAPEUTICS INC (NASDAQ:HALO): A GARP Stock with Strong Growth and Reasonable Valuation ↗

February 17, 2026

Via Chartmill

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

May 12, 2026

Via StockStory

Halozyme (HALO) Q1 2026 Earnings Transcript ↗

May 11, 2026

Via The Motley Fool

Halozyme Therapeutics Q1 Earnings Call Highlights ↗

May 11, 2026

Via MarketBeat

Halozyme Therapeutics’s (NASDAQ:HALO) Q1 CY2026 Sales Top Estimates

May 11, 2026

Via StockStory

Halozyme Therapeutics Earnings: What To Look For From HALO

May 09, 2026

Via StockStory

1 of Wall Street’s Favorite Stock with Exciting Potential and 2 That Underwhelm

April 21, 2026

Via StockStory

3 Cash-Producing Stocks with Exciting Potential

April 10, 2026

Via StockStory

2 Small-Cap Stocks with Solid Fundamentals and 1 We Ignore

April 09, 2026

Via StockStory

1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off

April 08, 2026

Via StockStory

Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks

March 24, 2026

Via StockStory

2 Reasons to Like HALO (and 1 Not So Much)

February 24, 2026

Via StockStory

Halozyme (HALO) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Via The Motley Fool

Halozyme Therapeutics (NASDAQ:HALO) Surprises With Q4 CY2025 Sales

February 17, 2026

Via StockStory

Acadia Healthcare, Hims & Hers Health, RadNet, Halozyme Therapeutics, and Privia Health Shares Are Soaring, What You Need To Know

February 13, 2026

Via StockStory

3 Small-Cap Stocks with Solid Fundamentals

February 08, 2026

Via StockStory

3 Growth Stocks Set to Flourish

February 01, 2026

Via StockStory

A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack

January 29, 2026

Via StockStory

Frequently Asked Questions

Is Halozyme Therapeutics, Inc. - Common Stock publicly traded?

Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?

Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?

The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market

What is the current price of Halozyme Therapeutics, Inc. - Common Stock?

The current price of Halozyme Therapeutics, Inc. - Common Stock is 66.28

When was Halozyme Therapeutics, Inc. - Common Stock last traded?

The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 06/02/26 04:00 PM ET

What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?

The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 9.43B

How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?

Halozyme Therapeutics, Inc. - Common Stock has 9B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.